Cardiac manifestations of Anderson-Fabry disease in heterozygous females

Journal of the American College of Cardiology

Volumn 40, Issue 9, 2002, Pages 1668-1674

  Kampmann, Christoph ^a,c   Baehner, Frank ^a   Whybra, Catharina ^a   Martin, Claudia ^a   Wiethoff, Christiane M ^a   Ries, Markus ^a   Gal, Andreas ^b   Beck, Michael ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; GLOBOTRIAOSYLCERAMIDE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; DIASTOLE; DISEASE SEVERITY; ENZYME REPLACEMENT; FABRY DISEASE; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMIZYGOTE; HETEROZYGOTE; HUMAN; LYSOSOME STORAGE DISEASE; MAJOR CLINICAL STUDY; MITRAL VALVE PROLAPSE; PREVALENCE; PRIORITY JOURNAL; SYSTOLE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; X CHROMOSOME LINKED DISORDER;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; ECHOCARDIOGRAPHY; FABRY DISEASE; FEMALE; HEART VALVE DISEASES; HETEROZYGOTE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; PEDIGREE; PREVALENCE; PROSPECTIVE STUDIES; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0037032275     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02380-X     Document Type: Article

References (26)

1. Meikle PJ, Hopwood JJ, Clague AE, et al. Prevalence of lysosomal storage disorders. JAMA 1999;281:249-54.
2. Desnick RJ, Ioannou YA, Eng CM. α-Galactosidase A deficiency: Fabry disease. In: Scriver CH, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill, 2001:3733-74.
3. Schiffmann R, Kopp JB, Austin HA III, et al. Enzyme replacement therapy in Fabry disease: A randomized controlled trial. JAMA 2001;285:2743-9.
4. Ferrans VJ, Hibbs RG, Burda CD. The heart in Fabry's disease. A histochemical and electron microscopic study. Am J Cardiol 1969;24: 95-110.
5. Linhart A, Palecek T, Bultas J, et al. New insights in cardiac structural changes in patients with Fabry's disease. Am Heart J 2000;139:1101-8.
6. Desnick RJ, Blieden LC, Sharp HL, et al. Cardiac valvular anomalies in Fabry disease. Clinical, morphologic, and biochemical studies. Circulation 1976;54:818-25.
7. Goldman ME, Cantor R, Schwartz MF, et al. Echocardiographic abnormalities and disease severity in Fabry's disease. J Am Coll Cardiol 1986;7:1157-61.
8. Pochis WT, Litzow JT, King BG, et al. Electrophysiologic findings in Fabry's disease with a short PR interval. Am J Cardiol 1994;74:203-4.
9. Elleder M, Dorazilova V, Bradova V, et al. Fabry's disease with isolated disease of the cardiac muscle, manifesting as hypertrophic cardiomyopathy. Cas Lek Cesk 1990;129:369-72.
10. Whybra C, Kampmann C, Willers I, et al. Anderson-Fabry disease: Clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis 2001;24:715-24.
11. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: Clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 2001;38:769-807.
12. Kampmann C, Wiethoff CM, Wenzel A, et al. Normal values of M-mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart 2000;83:667-72.
13. Devereux RB, Koren MJ, de Simone G, et al. Left ventricular hypertrophy as a measure of preclinical hypertensive disease. Am J Hypertens 1992;5:175S-81S.
14. Feigenbaum H. Echocardiography. 2nd Ed. Philadelphia, PA: Lea & Febinger, 1978.
15. Dumesnil JG, Shourci M, Laurenceau JL, et al. A mathematical model of the dynamic geometry of the intact left ventricle and its application to clinical data. Circulation 1979;59:1024-34.
16. Schmailzl KJG. Kardiale Ultraschalldiagnostik. Handbuch und Atlas, 1st Ed. Berlin: Blackwell Wissenschaft, 1994.
17. Bass JL, Shrivastava S, Grabowski GA, et al. The M-mode echocardiogram in Fabry's disease. Am Heart J 1980;100:807-12.
18. Gerdts E, Palmieri V, Otterstad JE, et al. Correlates of Left Atrial Size in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study (Abstr). American Heart Association 2001; ID100589.
19. Henein MY, Gibson DG. Long axis function in disease. Heart 1999;81:229-31.
20. Henein MY, Gibson DG. Suppression of left ventricular early diastolic filling by long axis asynchrony. Br Heart J 1995;73:151-7.
21. Peterson KL, Sklovan D, Ludbrook P, et al. Comparison of isovolumetric and ejection phase indices of myocardial performance in man. Circulation 1974;49:1088-96.
22. Cantor WJ, Butany J, Iwanochko M, et al. Restrictive cardiornyopathy secondary to Fabry's disease. Circulation 1998;98:1457-9.
23. Hillsley RE, Hernandez E, Steenbergen C, et al. Inherited restrictive cardiomyopathy in a 74-year-old woman: A case of Fabry's disease. Am Heart J 1995;129:199-202.
24. von Scheidt W, Eng CM, Fitzmaurice TF, et al. An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med 1991;324:395-9.
25. Elleder M, Bradova V, Smid F, et al. Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 1990;417:449-55.
26. Sakuraba H, Yanagawa Y, Igarashi T, et al. Cardiovascular manifestations in Fabry's disease. Clin Gener 1986;29:276-83.